AU5304900A - Salts of CIS-(4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate) - Google Patents

Salts of CIS-(4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate) Download PDF

Info

Publication number
AU5304900A
AU5304900A AU53049/00A AU5304900A AU5304900A AU 5304900 A AU5304900 A AU 5304900A AU 53049/00 A AU53049/00 A AU 53049/00A AU 5304900 A AU5304900 A AU 5304900A AU 5304900 A AU5304900 A AU 5304900A
Authority
AU
Australia
Prior art keywords
cyclohexan
cyclopentyloxy
methoxyphenyl
carboxylate
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53049/00A
Other languages
English (en)
Inventor
Guisha Kris Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU5304900A publication Critical patent/AU5304900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C261/00Derivatives of cyanic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/45Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU53049/00A 1999-05-25 2000-05-24 Salts of CIS-(4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate) Abandoned AU5304900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13573299P 1999-05-25 1999-05-25
US60135732 1999-05-25
PCT/US2000/014855 WO2000071114A1 (en) 1999-05-25 2000-05-24 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]

Publications (1)

Publication Number Publication Date
AU5304900A true AU5304900A (en) 2000-12-12

Family

ID=22469405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53049/00A Abandoned AU5304900A (en) 1999-05-25 2000-05-24 Salts of CIS-(4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate)

Country Status (20)

Country Link
EP (1) EP1194142A4 (ja)
JP (1) JP2003500356A (ja)
KR (1) KR20020010669A (ja)
CN (1) CN1351491A (ja)
AR (1) AR024076A1 (ja)
AU (1) AU5304900A (ja)
BR (1) BR0010483A (ja)
CA (1) CA2375543A1 (ja)
CO (1) CO5170527A1 (ja)
CZ (1) CZ20014186A3 (ja)
HK (1) HK1046630A1 (ja)
HU (1) HUP0201265A3 (ja)
IL (1) IL146213A0 (ja)
MX (1) MXPA01012048A (ja)
NO (1) NO20015699D0 (ja)
NZ (1) NZ515169A (ja)
PL (1) PL351945A1 (ja)
TR (1) TR200103238T2 (ja)
WO (1) WO2000071114A1 (ja)
ZA (1) ZA200109624B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043692A2 (en) * 1999-12-15 2001-06-21 Smithkline Beecham Corporation SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID
IN2014DN07867A (ja) * 2012-03-22 2015-04-24 Transtech Pharma Llc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019749A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
UY25338A1 (es) * 1998-01-07 2001-08-27 Smithkline Beecham Corp Método para tratar copd
WO2001043692A2 (en) * 1999-12-15 2001-06-21 Smithkline Beecham Corporation SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID

Also Published As

Publication number Publication date
WO2000071114A1 (en) 2000-11-30
TR200103238T2 (tr) 2002-02-21
EP1194142A1 (en) 2002-04-10
BR0010483A (pt) 2002-02-13
CO5170527A1 (es) 2002-06-27
EP1194142A4 (en) 2002-10-25
WO2000071114A8 (en) 2001-05-25
CZ20014186A3 (cs) 2002-04-17
HK1046630A1 (zh) 2003-01-24
HUP0201265A3 (en) 2003-03-28
JP2003500356A (ja) 2003-01-07
HUP0201265A2 (en) 2002-08-28
MXPA01012048A (es) 2002-05-06
AR024076A1 (es) 2002-09-04
KR20020010669A (ko) 2002-02-04
IL146213A0 (en) 2002-07-25
NZ515169A (en) 2003-05-30
NO20015699L (no) 2001-11-22
CN1351491A (zh) 2002-05-29
ZA200109624B (en) 2002-09-11
NO20015699D0 (no) 2001-11-22
CA2375543A1 (en) 2000-11-30
PL351945A1 (en) 2003-07-14

Similar Documents

Publication Publication Date Title
KR101641391B1 (ko) 퀴녹살린디온 유도체
PL192864B1 (pl) Pochodna pirazyny i środek farmaceutyczny
EP1728793A1 (en) 9-substituted 8-oxoadenine compound
WO1997013760A1 (en) Tricyclic fused compounds and pharmaceutical compositions containing them
JPH01500664A (ja) 置換キノリン誘導体、その製造法およびそれを含有する医薬組成物
JP2002540207A (ja) ピリミド[6,1−a]イソキノリン−4−オン誘導体
EP4180423A1 (en) Novel tnf activity inhibitor compound, and pharmaceutically acceptable salt thereof
TWI491607B (zh) 4,4’-(1-甲基-1,2-乙二基)-雙-(2,6-哌二酮)之新製法
CN108997355A (zh) 一种枸橼酸托法替尼化合物的精制方法
AU5304900A (en) Salts of CIS-(4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate)
PT95097B (pt) Processo aperfeicoado para a preparacao de amino acidos ciclicos
AU596927B2 (en) Pyrido (1,8) naphthyridinones and their use as pharmaceuticals
US7858807B2 (en) Method for producing 1-substituted-5-acylimidazole compound
US20140081020A1 (en) Methods of producing molindone and its salts
WO2011114338A1 (en) A process for the preparation of highly pure ambrisentan
US20030013905A1 (en) Salts of cis-4-cyano-4[3(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid
WO2001043692A2 (en) SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID
AU2007263393B2 (en) Polymorphic forms and process
HU226954B1 (en) Process for producing hydrazonic acids and pharmaceutical composition containing them
WO2012081036A2 (en) A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
WO2003027106A1 (en) Process for the preparation of crystalline polymorph ii of lamivudine
KR101183553B1 (ko) 퀴녹살린 유도체 또는 이의 염을 유효성분으로 포함하는 암 예방 또는 치료용 약학 조성물
US4929727A (en) Improved process for precipitating cytosine from alkaline solutions with sulfuric acid
EP0729456B1 (en) Novel process for preparing (s)-1-[2(s)-(1,3-dihydro-1,3-dioxo-isoindol-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4-tetrahydro-2-pyridine-carboxylic acid methyl ester and intermediates thereof
CN114380841A (zh) 作为akt抑制剂的三环喹唑啉或二氢喹唑啉化合物

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted